Benzalkonium Chloride Towelette Antiseptic | Rainier Medical

Features:

• Germicidal Power: Each towelette contains 0.13% w/v Benzalkonium Chloride, a proven antiseptic ingredient renowned for its efficacy against bacteria, fungi, algae, and enveloped viruses. This powerful solution ensures thorough disinfection, providing a reliable defense against a range of pathogens.
• Convenient Single-Use Design: The single-use, individually packaged towelettes offer a convenient and cost-effective solution for various disinfecting needs in foot care. Sized at 5 inches by 7 inches, these towelettes are sterile and latex-free, ensuring a hassle-free and efficient cleansing experience.
• Affordable Foot Care Solution: Rainier Medical understands the importance of affordability in foot care. Priced at only $9.25 for a box of 100 single-use packets, our Benzalkonium Chloride Towelette Antiseptic delivers cost-effective yet highly effective germicidal care, making it an essential tool for foot care professionals.
• Proven Virucidal Effect: Backed by pharmaceutical technology research, Benzalkonium Chloride has demonstrated a strong virucidal effect against various enveloped viruses, including SARS-CoV. With studies reporting log reductions, you can trust this antiseptic to provide a robust defense against viruses.

Benzalkonium Chloride Towelettes

By deactivating viruses through the disruption of lipid membranes, BKC is effective against a long list of enveloped viruses, including enteroviruses, rotaviruses, norovirus, influenza virus, severe acute respiratory syndrome coronavirus (SARS-CoV), rhinovirus, chlamydia, herpes simplex and hepatitis A.

As the need for effective yet safe antiviral products intensifies amid the Covid-19 pandemic, what is BKC’s virucidal effect when it comes to coronaviruses?

BKC and coronaviruses

Multiple studies have reported on the virucidal effect of BKC against coronaviruses. Rabenau et al. found that, as a surface disinfectant in concentration of 0.5%, BKC demonstrated a reduction factor of >4 against SARS-CoV. Meanwhile, by evaluating the virucidal activity of different oral rinses against three strains of SARS-CoV-2, Meister et al. reported log reductions of >3.11, >2.78 and >2.61 for a rinse containing 0.035% BKC.